Cormedix Earnings Estimates, EPS & Revenue | NASDAQ:CRMD

Comments

Cormedix Inc Earnings Estimates

CRMDNASDAQ

Trade with Public

$6.25

-0.05-0.79%

At close: Mar 20, 5:00 PM EST

$6.22

-0.028-0.45%

After Hours: Mar 20, 4:03 PM EST

Overview NewsEarningsOptions Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Cormedix Earnings Estimates, EPS & Revenue | NASDAQ:CRMD

Cormedix (CRMD) is scheduled to report Q1 earnings on May 5, 2026. Analysts estimate EPS of $0.38 and quarterly revenue of $106.59M.

In the most recent quarter (Q4), Cormedix reported EPS of $0.61, missing estimates of $0.83 by 0.27%. Revenue came in at $128.60M, exceeding the estimate of $127.13M by 0.01%.

Over the last 4 quarters, Cormedix has averaged an EPS surprise of 0.23% and a revenue surprise of 0.10%.

Earnings Date

May 5

EPS Estimate

$0.380

Quarterly Revenue Estimate

$106.59M

Annual Revenue
(as of Dec 31)

$311.71M

Cormedix Earnings History

Analyze the earnings history of Cormedix using advanced sorting and filters.

Loading calendar...

Cormedix (CRMD) Earnings Per Share

The chart below shows Cormedix's reported EPS compared to analyst estimates over recent quarters.

Cormedix (CRMD) Revenue

The chart below shows Cormedix's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Cormedix (NASDAQ:CRMD) reporting earnings?

Cormedix (CRMD) is scheduled to report earnings on May 5, 2026. The last reported earnings were for reported on March 5, 2026 for Q4.

What were the latest earnings per share (EPS) for Cormedix (NASDAQ:CRMD)?

The Actual EPS was $0.61, which missed the estimate of $0.83.

What were Cormedix’s (NASDAQ:CRMD) revenues?

The Actual Revenue was $128.60M, which beat the estimate of $127.13M.

People Also Watch

Atea Pharmaceuticals Inc

NASDAQ:AVIR

$5.67

0.18%

Theravance Biopharma Inc

NASDAQ:TBPH

$14.33

Zevra Therapeutics Inc

Neumora Therapeutics Inc

NASDAQ:NMRA

$2.54

1.16%

Aquestive Therapeutics Inc

NASDAQ:AQST

$4.06

2.01%

Esperion Therapeutics Inc

NASDAQ:ESPR

$2.56

0.25%

Cormedix Earnings Estimates, EPS & Revenue | NASDAQ:CRMD

Cormedix (CRMD) is scheduled to report Q1 earnings on May 5, 2026. Analysts estimate EPS of $0.38 and quarterly revenue of $106.59M.

In the most recent quarter (Q4), Cormedix reported EPS of $0.61, missing estimates of $0.83 by 0.27%. Revenue came in at $128.60M, exceeding the estimate of $127.13M by 0.01%.

Over the last 4 quarters, Cormedix has averaged an EPS surprise of 0.23% and a revenue surprise of 0.10%.

Earnings Date

May 5

EPS Estimate

$0.380

Quarterly Revenue Estimate

$106.59M

Annual Revenue
(as of Dec 31)

$311.71M